Using Blinatumomab in Acute Lymphoblastic Leukemia
0 vistas
• 06/15/23
0
0
Empotrar
administrator
Suscriptores
The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios